Apothecary By Design Progesterone Injection Recall: Container Closure Risk
Apothecary By Design recalls progesterone injections with potential container closure issues that may affect product integrity. Affected units have specific lot numbers and expiration dates.
Lower-risk recall
Lack of Processing Controls: The metal container closure adheres to the rubber stopper on some of the units of the batch which can impact the integrity of the container closure.
Contact the company
What happened, in plain English
Apothecary By Design is recalling progesterone injections in olive oil with benzyl alcohol that may have container closure problems. This could lead to product contamination or improper dosing if the container doesn't seal correctly. Read more at govinfonow.com/recall/41583-apothecary-by-design-progesterone-injection-recall-container-closure-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/41583-apothecary-by-design-progesterone-injection-recall-container-closure-risk · Updated October 8, 2026 · FDA enforcement record: FDA #D-0924-2017
Cite this page
“Apothecary By Design Progesterone Injection Recall: Container Closure Risk.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41583-apothecary-by-design-progesterone-injection-recall-container-closure-risk. Based on FDA recall #D-0924-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0924-2017%22&limit=1).
Why it’s dangerous
The metal container closure may stick to the rubber stopper in some units, which could compromise the container's integrity. This might allow contamination or improper dosing if the injection isn't handled correctly.
Who’s affected
Prescription users of this progesterone injection product are affected. Patients using the recalled batch may face potential contamination risks if the container doesn't seal properly.
How to tell if you have this one
Check for the lot number 04192017@1 on the vial label. The product expires September 30, 2017, and was sold by Apothecary By Design in Portland, ME.
- Brand
Apothecary By Design- Category
Drug
What to do — step by step
Check Vial Label
Look for the lot number 04192017@1 on the vial label to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 4 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0924-2017 (June 5, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0924-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.